Debut Biotech is a biotechnology company that is focused on developing new treatments for cancer. The company's approach is based on using machine learning algorithms to identify new drug targets and then developing drugs that target those targets. Debut Biotech's technology has the potential to significantly improve the speed and efficiency of drug discovery, which could lead to the development of new treatments for a wide range of diseases. The company was founded in 2018 and is headquartered in San Francisco, California.